Market Segmentation

• Offering– Products (Kits and Assays) and Services
• Sample – Stool, Urine, Saliva, and Other Samples
• Application – Oncology, Reproductive Health, Metabolic Disorders, and Other Applications
• Technology – Polymerase Chain Reaction (RT-PCR and dPCR), Sequencing (NGS and Sanger Sequencing), Microarray, and Other Technologies
• End User – Hospitals and Diagnostic Laboratories, Academic and Research Institutions, and Other End Users

Regional Segmentation

• North America – U.S., and Canada
• Europe – Germany, U.K., France, Italy, Spain, Netherlands, and Rest-of-Europe
• Asia-Pacific – China, Japan, India, South Korea, Australia, Singapore, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World

Market Growth Drivers

• Global Increase in Cancer Prevalence
• Increasing Government Funding for Healthcare
• Rise in Patient Preference for Non-Invasive Cancer Diagnosis
• Growing Prominence of Precision Medicine in the Oncology Ecosystem

Market Challenges

• False Negatives and Positives
• Lack of Favorable Reimbursement Policies
• Existing Diagnostic Confidence on Conventional Tissue-Based Biopsies

Market Opportunities

• Amalgamation of Artificial Intelligence (AI) with Non-Invasive Liquid Biopsy
• Massive Scope for the Adoption of Non-Invasive Liquid Biopsy Tests in the Emerging Markets

Key Companies Profiled

Bio-Techne Corporation, Endress + Hauser Group, Exact Sciences Corporation, Lonza Group AG, MDxHealth, Merck KGaA, MutantDx, Norgen Biotek Corp, Nucleix Ltd., Oasis Diagnostics Corporation, OraSure Technologies, Inc., PerkinElmer Inc., Predicine, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Zymo Research Corporation

Key Questions Answered in this Report:

• How is non-invasive liquid biopsy revolutionizing the field of oncology, reproductive health, and metabolic disorders?
• What are the major market drivers, challenges, and opportunities in the global non-invasive liquid biopsy market?
• What are the underlying structures resulting in the emerging trends within the global non-invasive liquid biopsy market?
• How did the COVID-19 pandemic impact the global non-invasive liquid biopsy ecosystem?
• What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
• What are the key regulatory implications in developed and developing regions pertaining to the use of non-invasive liquid biopsy?
• What are the potential entry barriers, which are expected to be faced by the companies willing to enter a particular region?
• How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:
o Offering (products and services)
o Sample (stool, urine, saliva, and other samples)
o Technology (sequencing, polymerase chain reaction (PCR), microarray, and other technologies)
o Application (oncology, reproductive health, metabolic disorders, and other applications)
o End User (academic and research institutions, hospitals and diagnostic laboratories, and other end users)
o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
• What are the growth opportunities for the non-invasive liquid biopsy companies in the region of their operation?
• Who are the leading players with significant offerings in the global non-invasive liquid biopsy market?
• Which companies are anticipated to be highly disruptive in the future, and why?

Market Overview

Our healthcare experts have found the non-invasive liquid biopsy industry to be one of the most rapidly evolving and dynamic markets, and the global market for non-invasive liquid biopsy is predicted to grow at a CAGR of 20.38% over the forecast period 2021-2031. The market is driven by certain factors, which include a global increase in cancer prevalence, increasing government funding for healthcare, rise in patient preference for non-invasive cancer diagnosis, and growing prominence of precision medicine in the oncology ecosystem.

The market is favored by the developments in the field of cancer molecular diagnostic testing and its attributes such as non-invasive liquid biopsy. Currently, the non-invasive liquid biopsy industry is witnessing an upsurge due to the global increase in cancer prevalence, increasing government funding for healthcare, rise in patient preference for non-invasive cancer diagnosis, and growing prominence of precision medicine in the oncology ecosystem.

Furthermore, biotechnology companies are focusing on the development of robust non-invasive liquid biopsy solutions for a wide range of applications, including oncology, reproductive health, metabolic disorders, to support clinicians to unravel insights pertaining to the analysis of genetic alterations present in the circulating biomarkers in samples such as stool, urine, and saliva. The development of non-invasive liquid biopsy products and services enabled clinicians to offer early cancer screening and diagnosis to patients, further improving survival rates.

Within the research report, the market is segmented on the basis of offering, sample, application, technology, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the number of cases associated with cancer has created a buzz among the biotechnology companies to further invest in the development of innovative cancer diagnostics, including non-invasive liquid biopsy, further aiding physicians to offer value-based clinical outcomes to patients. Due to the established presence of Exact Sciences Corporation in the U.S. market, offering its proprietary Cologuard test, the company has been the leading player in the non-invasive liquid biopsy ecosystem.

On the basis of region, North America holds the largest share of the non-invasive liquid biopsy market due to high infusion of funding from the government organizations for conducting cancer research, increasing prevalence of cancer, presence of market juggernauts in the region, growing awareness about non-invasive liquid biopsy products, and increasing awareness about early cancer screening. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period 2021-2031.

Global Liquid Biopsy Market Analysis & Forecast 2016 To 2022

The post Global Non-Invasive Liquid Biopsy Market: Focus on Offering, Sample, Application, Technology, End Users, Country Data (16 Countries), and Competitive Landscape – Analysis and Forecast, 2021-2031 first appeared on CRI Report.

Expert Quote

“I think these are exciting times. Not considering the buzz around AI, ultimately, it is an enabler to do things at scale and quickly. It needs to serve a higher purpose that provides surgeons or other stakeholders in the healthcare ecosystem with value. The real value that a company provides with AI is the key component. This technology can be leveraged to tackle the disparity in the world of surgery”.

Market Segmentation

• Offering (Hardware and Software-a-a-Service (SaaS))
• Technology (Machine Learning, Deep Learning, Natural Language Processing (NLP), and Other Technologies)
• Indication (Neurotechnology, and Neurosurgery)
• Application (Training, Diagnosis, Surgical Planning and Rehabilitation, Outcomes and Risk Analysis, Integration and Connectivity, and Others)
• End User (Hospitals and Others (Including Ambulatory Surgical Centers, Standalone, and Specialized Facilities))

Regional Segmentation

• North America (U.S. and Canada)
• Europe (Germany, U.K., France, Italy, Spain, Nordic Countries, and Rest-of-Europe)
• Asia-Pacific (Japan, China, South Korea, Australia and New Zealand, India, and Rest-of-Asia-Pacific)
• Latin America (Brazil, Mexico, Argentina, and Rest-of-Latin America)
• Middle East and Africa

Growth Drivers

• Growth in Funding for AI
• Growing Adoption of AI-Enabled Technologies in Healthcare Settings
• Advancement in Robotics and Medical Visualization Technologies
• Benefits of Artificial Intelligence-Enabled Surgeries Over Conventional Surgeries

Market Challenges

• Lack of a Well-Defined Regulatory Framework in Regions
• Limited Studies and Data on the Efficiency of AI in Neurology Operating Rooms

Market Opportunities

• Leverage AI to Enhance Remote Surgical Capabilities
• Leveraging Business Synergies for Capability and Portfolio Enhancement

Key Companies Profiled

Activ Surgical, Inc., Brainomix Ltd, Caresyntax, Inc., DeepOR S.A.S, ExplORer Surgical Corp., Holo Surgical Inc., LeanTaaS Inc., Medtronic Plc, Proximie, Scalpel Limited, and Theator Inc.

Key Questions Answered in this Report:

• How has COVID-19 impacted the adoption of AI in neurology operating room?
• What are the key regulations governing the AI in neurology operating room market in key regions?
• What are the technological developments which are expected to have the maximum influence on the global AI in neurology operating room market?
• Who are the leading players holding significant dominance in the global AI in neurology operating room market currently?
• How do end users of artificial intelligence in operating rooms perceive the technology?
• What are the key business models being followed by the key players in the market?
• What are some of the major factors which are expected to influence the growth in the adoption of AI in neurology operating room across the globe?
• What are the key strategies incorporated by leading players in the global AI in neurology operating room market landscape?
• What is the current revenue contribution for the different product types in the global AI in neurology operating room market, and what are the expected modifications in the forecast period?

Key USPs of the Report

Following are some of the key contents of the report:

• Funding Scenario
This section encompasses a description of the current funding landscape in the global AI in neurology operating room space for key players.

• Patent Scenario
This section encompasses a description of the current patent landscape in the field of AI in the neurology operating room.

• Regulatory Framework
This section comprises information on the regulatory framework for various regulatory bodies associated with granting approval to AI platforms/technologies for application in the neurology operating room.

• Impact of COVID-19
This section of the report encompasses the following:
o Impact on AI adoption in surgery
o Future impact (Short- and long-term)
o Key developments during the COVID-19 pandemic

In addition, the report provides:

• A detailed analysis and growth forecast (2021-2030) for different market segments
• Recent developments and trends in the global market landscape
• Factors promoting and inhibiting the market growth
• Case studies to assess the key strategies adopted by some of the highly funded players in the market

Scope of the Global AI in Neurology Operating Room Market

The purpose of the study is to enable the reader to gain a holistic view of the global AI in neurology operating room market by each of the aforementioned segments.

The report constitutes an in-depth analysis of the global AI in neurology operating room market, including a thorough analysis of the applications. The study also provides market and business-related information on various products, applications, technologies, and end users. The report considers software solutions and hardware solutions integrated with AI.

Key Companies in the Global AI in Neurology Operating Room Market

Some of the key players contributing to the global AI in neurology operating room market include Activ Surgical, Inc., Brainomix Ltd, Caresyntax, Inc., DeepOR S.A.S, ExplORer Surgical Corp., Holo Surgical Inc., LeanTaaS Inc., Medtronic Plc, Proximie, Scalpel Limited, and Theator Inc.

Hospital EMR Systems Market: Market Segments: By Product Type (Inpatient EMR and Outpatient EMR); By Component (Software and Services); By Application (Cardiology, Neurology, Radiology, Oncology and Others); By End-User (Hospital-based EMR and Physician-based EMR); and Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

The post Global Artificial Intelligence (AI) in Neurology Operating Room Market: Focus on Offering, Technology, Indication, Application, End User, Unmet Demand, Cost-Benefit Analysis, and Over 16 Countries’ Data – Analysis and Forecast, 2021-2030 first appeared on CRI Report.

Market Segmentation

• Application Type – Residential, Commercial, Industrial, Outdoor, and Automotive
• Component Type – Fixture and Control
• Technology Type – Wired and Wireless

Regional Segmentation

• North America – U.S. and Canada
• Latin America
• Europe – Germany, France, Spain
• U.K.
• Middle East and Africa
• China
• Asia-Pacific and Japan – Japan, South Korea, India

Growth Drivers

• Prevailing Issue of Global Energy Crisis Supporting the Adoption of Smart Lighting
• Increasing Trend of Smart Homes along with Customization Benefits Supports Smart Lighting Market
• Continually Declining Average Selling Price (ASP) of LED Bulbs
• Development of Smart Cities

Market Challenges

• Security and Privacy Concerns
• Design Challenges with LED Usage
• Consumers Having to Bear High Replacement Costs to Switch from Existing Solutions to Smart Lighting
• Lack of Standards and the Associated Interoperability Issues

Market Opportunities

• Advancement in Lighting Control
• Integration of Physical Security Industry with Smart Lighting
• Changing Paradigm of Lighting Industry to Electronics Industry
• Adding Voice Control Feature to the Upcoming Products
• Consumer Awareness for Energy Conservation

Key Companies Profiled

Acuity Brands Inc., ams AG, CommScope Holding Company Inc., Control4 Corporation, General Electric Company, Honeywell International Inc., NXP Semiconductors NV, OSRAM Licht AG, Signify (Philips Lighting), and Zumtobel Group AG

Key Questions Answered in this Report:

• What is the global smart lighting market size in terms of volume and revenue from 2019 to 2025?
• How is the industry expected to evolve during the forecast period 2021-2025?
• What has been the impact of COVID-19 on the smart lighting market?
• Which region will lead the global smart lighting market by 2025?
• Which application will lead the global smart lighting market by 2025?
• What are the driving factors for the global smart lighting market from 2019 to 2025?
• What are the underlying structures resulting in the emerging trends within the smart lighting market?
• Which factors are impeding the growth of the global smart lighting market?
• What is the role of governments regarding environmental issues and safety changing the landscape of the smart lighting market?
• What are the growth opportunities and critical success factors for participants to compete in this market?
• Who are the leading players in the global smart lighting market along with their ranking?
• What are the key developmental strategies implemented by the key players to sustain in the competitive market?

Market Overview

The increasing worldwide demand for energy is responsible for a rise in energy prices, tight energy supplies, and growing anxiety about climate change and related liabilities. The lighting segment consumes most of the electricity in residential, commercial, and industrial sectors. Lighting accounts for 15% of total electricity consumption and 5% of total greenhouse gas emissions worldwide. The future global economy is expected to consume more energy resources, especially with the growing energy demand from developing countries, such as China and India. Additionally, the risk of climate change associated with the use of fossil fuels has made the supply of energy increasingly difficult. Amidst the increasing energy demand and environmental concern, smart lighting systems are gaining popularity and are expected to grow at a noteworthy rate in the coming years. With the installation of the smart lighting system in a building, 50% of energy costs can be saved, enhancing the productivity and comfort of the user.

The report further considers the market dynamics, supply chain analysis, and the detailed product contribution of the key players operating in the market. The global smart lighting market report is a compilation of different segments, including market breakdown by component type, application, technology, region, and country.

The global smart lighting market, based on component type, has been categorized into fixture and control. The fixture category is expected to maintain its dominance during the forecast period. Further, the fixtures are subcategorized into key products – compact fluorescent lights (CFL), light-emitting diode (LED), organic light-emitting diode (OLED), high-intensity discharge (HID) lamps, and plasma lamps. The control category is further subcategorized into sensors, microprocessors and controllers, dimmers and switches, wireless transmitters and receivers, and ballasts and LED drivers

The global smart lighting market, by technology, has been categorized into wired and wireless technology. The wired segment dominated the global smart lighting market in 2020 and is expected to maintain its dominance through the forecast period.

Based on application, the global smart lighting market is categorized into residential, commercial, industrial, outdoor, and automotive. Smart lighting has maximum usage in residential applications. The increasing number of smart homes coupled with customization benefits are pushing the growth of the global smart lighting market in residential applications.

Based on the region, the global smart lighting market has been segmented into Asia-Pacific and Japan, Europe, the U.K., China, North America, South America, and the Middle East and Africa. Each region is segmented into countries. Data for each of these regions and countries is provided by the application, component type, and technology.

Competitive Landscape

The global smart lighting market competitive landscape consists of different strategies undertaken by key players across the industry to gain traction and market share presence. Some strategies adopted by the service providers are new product launches, business expansions, mergers, partnerships, and collaborations. Among all these strategies adopted, product launch is the popular choice of the strategy implemented in the smart lighting market. Some of the most prominent ecosystem players are Acuity Brands Inc., ams AG, CommScope Holding Company Inc., Control4 Corporation, General Electric Company, Honeywell International Inc., NXP Semiconductors NV, OSRAM Licht AG, Koninklijke Philips N.V., and Zumtobel Group AG.

The post Smart Lighting Market – A Global Market and Regional Analysis: Focus on Smart Lighting Product and Application, Supply Chain Analysis, Country Analysis, and Impact of COVID-19 Period – Analysis and Forecast, 2019-2025 first appeared on CRI Report.